# Nuclide record b-reimbursement-coding (bottleneck). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/bottlenecks/b-reimbursement-coding/>
  a schema:Thing ;
  nuclide:kind "bottleneck" ;
  schema:identifier "b-reimbursement-coding" ;
  schema:name "Reimbursement and coding for radiopharmaceuticals"@en ;
  schema:description "In the US, insurance pays extra for a new radioactive scan for a couple of years, then that extra payment can suddenly stop, even though the drug still costs the same to make. That cliff has already made at least one scan much harder for patients to get."@en ;
  schema:url <https://nuclide.cc/bottlenecks/b-reimbursement-coding/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://snmmi.org/Web/Web/News/Articles/FAQs-on-the-Centers-for-Medicare---Medicaid-Services--CMS--Major-Payment-Policy-Reform-for-Diagnosti.aspx>, <https://www.acr.org/Clinical-Resources/Publications-and-Research/ACR-Bulletin/Changes-to-Reimbursement-for-High-Cost-Radiopharmaceuticals>, <https://www.mcguirewoods.com/client-resources/alerts/2025/4/radiopharmaceutical-industry-update-q4-q1-2024-2025/>, <https://www.astro.org/getmedia/8ac4db0c-cd58-42bd-b693-7caa40928919/2025HOPPSFinalRuleSummary.pdf> ;
  nuclide:tag "reimbursement", "CMS", "coding", "access" ;
  nuclide:related <https://nuclide.cc/bottlenecks/b-site-readiness-referral/>, <https://nuclide.cc/bottlenecks/b-mo99-supply/>, <https://nuclide.cc/isotopes/tc-99m/>, <https://nuclide.cc/isotopes/mo-99/> ;
  nuclide:technologies <https://nuclide.cc/technologies/pet-tracer-manufacturing/>, <https://nuclide.cc/technologies/radiopharmacy-network/> ;
  nuclide:drugs <https://nuclide.cc/drugs/pylarify/>, <https://nuclide.cc/drugs/illuccix/>, <https://nuclide.cc/drugs/locametz/>, <https://nuclide.cc/drugs/pluvicto/>, <https://nuclide.cc/drugs/lutathera/> ;
  nuclide:companies <https://nuclide.cc/companies/novartis/>, <https://nuclide.cc/companies/telix/>, <https://nuclide.cc/companies/lantheus/> ;
  nuclide:institutions <https://nuclide.cc/institutions/snmmi/> .